BioGaia
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
BIOG | ST
Overview
Corporate Details
- ISIN(s):
- SE0017769987 (+1 more)
- LEI:
- 549300UBUJOY2L7TT361
- Country:
- Sweden
- Address:
- Box 3242, 103 64 Stockholm
- Website:
- https://www.biogaia.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioGaia is a biotechnology company specializing in the research, development, and commercialization of probiotic products. Since its founding in 1990, the company has focused on developing clinically proven probiotics to support digestive health and overall well-being for all life stages. Its product portfolio is based on patented strains of Lactobacillus, with key offerings like the BioGaia Protectis® line. This includes probiotic drops for infants, which are researched to help with common digestive issues such as colic, constipation, and diarrhea. BioGaia positions itself as a science-driven leader in its field, providing products that help maintain a healthy intestinal microflora.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioGaia and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-22 17:30 |
Post-Annual General Meeting Information
Extra bolagsstämma i BioGaia
|
Swedish | 149.3 KB | |
| 2025-08-22 17:30 |
Board/Management Information
Extraordinary General Meeting of BioGaia
|
English | 71.0 KB | |
| 2025-07-25 09:31 |
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma i BioGaia AB (publ)
|
Swedish | 169.8 KB | |
| 2025-07-25 09:31 |
Pre-Annual General Meeting Information
Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)
|
English | 199.0 KB | |
| 2025-07-18 08:01 |
Interim Report
|
Swedish | 20.6 MB | |
| 2025-07-18 08:01 |
Interim Report
|
English | 18.4 MB | |
| 2025-06-18 14:20 |
Major Shareholding Notification
|
Swedish | 10.0 KB | |
| 2025-05-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Förändrat antal röster i BioGaia AB (publ)
|
Swedish | 261.2 KB | |
| 2025-05-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in the number of votes in BioGaia AB (publ)
|
English | 231.4 KB | |
| 2025-05-21 14:04 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 10.0 KB | |
| 2025-05-20 13:01 |
Major Shareholding Notification
|
Swedish | 10.7 KB | |
| 2025-05-14 16:43 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 10.0 KB | |
| 2025-05-12 16:39 |
Major Shareholding Notification
|
Swedish | 10.0 KB | |
| 2025-05-07 18:30 |
Post-Annual General Meeting Information
Annual General Meeting of BioGaia
|
English | 88.0 KB | |
| 2025-05-07 18:30 |
Post-Annual General Meeting Information
Årsstämma i BioGaia
|
Swedish | 134.6 KB |
Automate Your Workflow. Get a real-time feed of all BioGaia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BioGaia via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-08 | Barbro Fridén | Other | Buy | 188 | 19,627.20 SEK |
| 2024-09-13 | Linda Hägglund | Other | Sell | 2,000 | 233,800.00 SEK |
| 2024-09-12 | Linda Hägglund | Other | Sell | 994 | 115,502.80 SEK |
| 2024-09-12 | Linda Hägglund | Other | Sell | 6 | 697.80 SEK |
| 2024-06-10 | Outi Armstrong | Other | Buy | 1,000 | 125,400.00 SEK |
| 2023-08-02 | Anthon Jahreskog | Other | Buy | 481 | 51,515.10 SEK |
| 2023-08-02 | Anthon Jahreskog | Other | Buy | 169 | 18,083.00 SEK |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
